ACI’s Hatch-Waxman Series 2023 Advisory Board
American Conference Institute’s Hatch-Waxman Series Advisory board was created as a part of ACI’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of all-in-house advisers, including Chief IP and very senior IP/Patent counsel from the leading brand name and generic pharmaceutical companies in the country and in some cases the world. This ‘inner circle’ counsels ACI on the impact of litigation trends and emerging topics.
Advisory Board
Ryan M. Daniel
AGC, Corporate and Business Transactions
Fresenius Kabi
Stephanie Donahue
Principal Counsel, Patent Litigation
Sanofi
Serena Farquharson Torres
Executive Director, Assistant General Counsel, Innovation Law
Bristol Myers Squibb
Linda Friedlieb
Division Counsel
AbbVie
Andrea Hutchison
Vice President, Intellectual Property Litigation
Gilead Sciences
Staci Julie
SVP and Chief IP Counsel
Teva Pharmaceuticals
James Kellerman
Senior Vice President, Intellectual Property
Astellas Pharma US, Inc.
Neema Kumar
Vice President, IP, North America
Sandoz
James P. Leeds
Assistant General Patent Counsel
Eli Lilly & Company
Mary Morry
Counsel, IP Litigation
Merck & Company
Jeffrey N. Myers, Ph.D.
Vice President & Assistant General Counsel
Pfizer Inc
Aaron Pereira
Senior Director of Patents
Ferring Pharmaceuticals
Pearl T. L. Siew
Senior Vice President and Head of IP
Design Therapeutics
Brian Stone
Associate General Counsel
Global Legal-Regulatory
Viatris
Lars P. Taavola
VP, Chief IP Counsel & General Counsel, Specialty Generics
Mallinckrodt Pharmaceuticals
Maryll W. Toufanian
Senior Vice President, Regulatory Strategy and Policy
Amneal Pharmaceuticals
Peter Waibel
Head, Patent Litigation (US)
Novartis Pharmaceuticals Corporation
Kevin Zive
Vice President - General Counsel, and Head of Global Intellectual Property
Apotex Inc.
Emeritus Members
Stephen R. Auten
Partner, Chair of Pharmaceutical & Life Sciences Litigation
Taft Stettinius & Hollister LLP
(Former Vice President, IP, Sandoz, Inc.)
Guy Donatiello
Legal Executive / Intellectual Property Attorney (Former Senior Vice President, Intellectual Property, Endo Pharmaceuticals)
George W. Johnston
Counsel
Gibbons P.C.
(Former Vice President & Chief Patent Counsel, Hoffmann-La Roche)
David Silverstein
Partner
Axinn, Veltrop & Harkrider LLP
Meg Snowden
Shareholder
Margaret M. Snowden, P.C.
(Former Vice President,, Intellectual Property, Impax Laboratories)
